Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

Lakeland Fire + Safety’s fiscal year 2025, which ended January 31 st, was a transformative year in many ways, underscored by multiple successful acquisitions to build a head-to-toe portfolio of brands ...

The NGO Doctors for America argued that HHS, CDC and FDA violated federal law in removing medical information from ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

U.S. District Judge John D. Bates granted a restraining order temporarily reversing the Trump administration’s moves to ...

A judge ordered federal health agencies to restore webpages about medical treatments that were removed under a Trump administration order.

In a two-page ruling, U.S. District Judge John Bates ordered HHS, the FDA and the CDC to restore the pages and datasets identified in DFA's complaint. Some of the pages that were taken down were: ...

KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and use of the product has expanded across the U.S. The Company is taking the ...

A federal judge has told government agencies to restore public access to health-related webpages and datasets they removed to ...

A group of doctors urged a federal judge to order the Centers for Disease Control and Prevention to restore webpages taken down under a Trump order.

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...